Recent VVOS News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2025 01:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 12:55:50 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/11/2025 09:26:17 PM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 01/31/2025 10:00:49 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/31/2025 05:15:16 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/29/2025 11:04:31 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2025 11:09:43 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2024 12:06:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 10:29:18 PM
- Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 12/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2024 10:25:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 09:47:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:20:10 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:05:24 PM
- Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/14/2024 09:05:00 PM
- Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 11/13/2024 10:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2024 09:15:11 PM
- Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/24/2024 06:59:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:05:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/20/2024 12:00:29 PM
- Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Healthcare Shares Pop On FDA Clearance • AllPennyStocks.com • 09/18/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:00:16 PM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM